← back to search

Dongyan Cai

Dalian Medical University · CN

Area of research

Oncology · Pulmonary and Respiratory Medicine

Research interest

Research interests include In vivo, Cancer research, Cancer, FOXO1, Chemistry, and Medicine.

h-index

—

citations

55

works

2

NIH funding

—

primary concept

—

email

✉ Find email ↗

Recent publications

Disitamab vedotin (DV) plus toripalimab (Tor) and chemotherapy (C)/trastuzumab (Tra) as first-line (1L) treatment of patients (pts) with HER2-expressing locally advanced or metastatic (la/m) gastric cancer.

Journal of Clinical Oncology 2025cited by 7position: middledoi

Cold atmospheric plasmas target breast cancer stemness via modulating AQP3-19Y mediated AQP3-5K and FOXO1 K48-ubiquitination

International Journal of Biological Sciences 2022cited by 48position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Meili Sun · Shandong University1 papers (2025–2025)Xiang Wang · Xuzhou Medical College1 papers (2025–2025)Feng Ye · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2025–2025)Lin Shen · Ministry of Education1 papers (2025–2025)Ting Deng · Tianjin Medical University1 papers (2025–2025)Xiaofeng Dai · Nanchang University1 papers (2022–2022)Peiyu Wang · Xiamen University1 papers (2022–2022)Hua Dong · University of California, Davis1 papers (2022–2022)— · 1 papers (2025–2025)— · 1 papers (2025–2025)Yin Jin · Wenzhou Medical University1 papers (2025–2025)Yanqiao Zhang · Harbin Medical University1 papers (2025–2025)Jianying Zhang · University of Massachusetts Chan Medical School1 papers (2022–2022)— · 1 papers (2025–2025)Nan Nan · York University1 papers (2022–2022)Jun Zhang · Qingdao University1 papers (2025–2025)Huiting Xu · Nantong University1 papers (2025–2025)Kostya Ostrikov · Queensland University of Technology1 papers (2022–2022)Jianzhi Liu · Jiangsu University1 papers (2025–2025)Renwu Zhou · Xi'an Jiaotong University1 papers (2022–2022)